AbbVie (ABBV) Announces FDA Approval of VRAYLAR

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. SPY
2. PATH
3. KBH
4. AZO
5. USO
6. QQQ
7. ORCL
8. RCL
9. ONON
10. BA

Go back to AbbVie (ABBV) Announces FDA Approval of VRAYLAR
AbbVie (NYSE: ABBV) Delayed: 265.08 -0.13 (0.05%)
Previous Close $265.21    52 Week High $68.12 
Open $266.00    52 Week Low $50.71 
Day High $269.39    P/E 57.50 
Day Low $263.59    EPS $4.61 
Volume 3,468,906